{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T23:40:16Z","timestamp":1793922016901,"version":"4.8.0"},"reference-count":83,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,5,26]],"date-time":"2026-05-26T00:00:00Z","timestamp":1779753600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,5,26]],"date-time":"2026-05-26T00:00:00Z","timestamp":1779753600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Commun Med"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>The continued emergence of SARS-CoV-2 variants with increased transmissibility and immunoevasive properties highlights the necessity to complement genomic surveillance with epidemiological data and laboratory-based assessment of viral phenotypes. Effective surveillance tools must be scalable, cost-efficient, and able to detect and characterize emerging variants in timely manner.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We utilized the Integrated Molecular Surveillance for SARS-CoV-2 (IMSSC2) network to conduct nationwide integrated SARS-CoV-2 genomic surveillance in Germany. SARS-CoV-2-positive samples from diagnostic laboratories were routinely subjected to whole genome sequencing. Epidemiological data from COVID-19 cases infected with BA.1, BA.2, BA.5.1, BQ.1.1, XBB.1.5, XBB.1.9.1, and XBB.1.9.2, notified between 1 December 2021 and 30 April 2023, were analyzed. Complementary, representative virus isolates were examined for immunoevasive properties and replication in human respiratory infection models.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Lineage assignments of 4595 SARS-CoV-2 genomes indicate ongoing viral evolution with successive replacement of dominant variants from Delta to Omicron lineages BA.1, BA.2, BA.5.1, BQ.1, and XBB recombinants. Age-stratified epidemiological analyses show higher proportions of BA.1 and BA.2 infections in children. Multivariable logistic regression identifies male sex and increasing age as significant predictors of hospitalization. Phenotypic characterization suggests ongoing adaptation of Omicron variants BA.2, BQ.1.1, XBB.1.5, and XBB.1.9.2 to the upper human respiratory tract and enhanced propagation of XBB.1.9.2 in an alveolar infection model.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Integrated genomic, epidemiological and virological approaches enable early assessment of emerging SARS-CoV-2 lineages and demonstrate ongoing adaptation across the human respiratory tract. Our findings show that geographically representative, scalable surveillance provides robust insights into viral evolution, supporting sustainable surveillance beyond the acute pandemic phase.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1038\/s43856-026-01647-x","type":"journal-article","created":{"date-parts":[[2026,5,26]],"date-time":"2026-05-26T16:26:23Z","timestamp":1779812783000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Monitoring viral evolution and epidemiological characteristics of SARS-CoV-2 during 2022\u20132023 using Integrated Genomic Surveillance"],"prefix":"10.1038","volume":"6","author":[{"given":"Christin","family":"Mache","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8152-8189","authenticated-orcid":false,"given":"Romy","family":"Kerber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jessica","family":"Schulze","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3637-5870","authenticated-orcid":false,"given":"Marie","family":"Lataretu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susan","family":"Abunijela","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0001-8566-8207","authenticated-orcid":false,"given":"Yusra","family":"Seyam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2608-2596","authenticated-orcid":false,"given":"Sofia","family":"Paraskevopoulou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0541-6155","authenticated-orcid":false,"given":"Djin-Ye","family":"Oh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maximilian","family":"Arlt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aleksandar","family":"Radoni\u0107","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-4964-4468","authenticated-orcid":false,"given":"Somayyeh","family":"Sedaghatjoo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5960-515X","authenticated-orcid":false,"given":"Matthias","family":"Budt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ann-Sophie","family":"Lehfeld","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3902-8524","authenticated-orcid":false,"given":"Felix","family":"Hartkopf","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3432-0438","authenticated-orcid":false,"given":"Ralf","family":"D\u00fcrrwald","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2225-7267","authenticated-orcid":false,"given":"Torsten","family":"Semmler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Walter","family":"Haas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1338-2699","authenticated-orcid":false,"given":"Stephan","family":"Fuchs","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9457-4798","authenticated-orcid":false,"given":"Stefan","family":"Kr\u00f6ger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7688-236X","authenticated-orcid":false,"given":"Thorsten","family":"Wolff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"Integrated Molecular Surveillance for SARS-CoV-2 (IMSSC2) Laboratory Network","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gerald","family":"von Hermanni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Felix","family":"Stelter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Gropp","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bernhard","family":"Miller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrick","family":"Chhatwal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christina","family":"Kiel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abdullah Al","family":"Mamun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Konrad A.","family":"Bode","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Veronika","family":"Balau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anja","family":"Kruggel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roger","family":"Grosser","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aida","family":"Bajraktarevic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ralf","family":"Ignatius","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juliane","family":"Flindt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ingo","family":"Neumann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manuel","family":"Haffner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jana","family":"L\u00f6bner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karsten","family":"Mydlak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andi","family":"Krumbholz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Lorentz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Semir","family":"Doric","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"M\u00fcller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Denise","family":"Buhlmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beate","family":"Hermann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudia","family":"Gerlich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andreas","family":"Gerritzen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carsten","family":"Tiemann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Udo","family":"Geipel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bettina","family":"Georg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meike","family":"Voss","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandra","family":"Dehn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Friedemann","family":"Tewald","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrick","family":"Finzer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lea","family":"Klar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Florian","family":"Szabados","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Erren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jerzy Roch","family":"Nofer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexa","family":"Laubner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Markus","family":"Petzold","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annika","family":"Brinkmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andreas","family":"Nitsche","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christin","family":"Mache","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jessica","family":"Schulze","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,5,26]]},"reference":[{"key":"1647_CR1","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1038\/s41586-020-2012-7","volume":"579","author":"P Zhou","year":"2020","unstructured":"Zhou, P. et al. A pneumonia outbreak associated with a new coronavirus of probable bat origin. Nature 579, 270\u2013273 (2020).","journal-title":"Nature"},{"key":"1647_CR2","doi-asserted-by":"publisher","unstructured":"Viana, R.et al. Rapid epidemic expansion of the SARS-CoV-2 Omicron variant in southern Africa. Nature https:\/\/doi.org\/10.1038\/s41586-022-04411-y (2022).","DOI":"10.1038\/s41586-022-04411-y"},{"key":"1647_CR3","doi-asserted-by":"publisher","first-page":"1952","DOI":"10.1038\/s41564-023-01504-w","volume":"8","author":"C Roemer","year":"2023","unstructured":"Roemer, C. et al. SARS-CoV-2 evolution in the Omicron era. Nat. Microbiol. 8, 1952\u20131959 (2023).","journal-title":"Nat. Microbiol."},{"key":"1647_CR4","doi-asserted-by":"publisher","first-page":"2376","DOI":"10.1002\/jmv.27643","volume":"94","author":"D Tian","year":"2022","unstructured":"Tian, D., Sun, Y., Xu, H. & Ye, Q. The emergence and epidemic characteristics of the highly mutated SARS-CoV-2 Omicron variant. J. Med Virol. 94, 2376\u20132383 (2022).","journal-title":"J. Med Virol."},{"key":"1647_CR5","doi-asserted-by":"publisher","first-page":"896","DOI":"10.1038\/s41564-022-01135-7","volume":"7","author":"A Aggarwal","year":"2022","unstructured":"Aggarwal, A. et al. Platform for isolation and characterization of SARS-CoV-2 variants enables rapid characterization of Omicron in Australia. Nat. Microbiol. 7, 896\u2013908 (2022).","journal-title":"Nat. Microbiol."},{"key":"1647_CR6","doi-asserted-by":"publisher","first-page":"772","DOI":"10.1038\/s42003-023-05081-w","volume":"6","author":"T Tamura","year":"2023","unstructured":"Tamura, T. et al. Comparative pathogenicity of SARS-CoV-2 Omicron subvariants including BA.1, BA.2, and BA.5. Commun. Biol. 6, 772 (2023).","journal-title":"Commun. Biol."},{"key":"1647_CR7","unstructured":"Bundesministerium f\u00fcr Gesundheit. Verordnung zur molekulargenetischen Surveillance des Coronavirus SARS-CoV-2 (Coronavirus-Surveillanceverordnung \u2013 CorSurV), 2021)."},{"key":"1647_CR8","unstructured":"Robert Koch-Institut. Kriterien f\u00fcr die anlass\u00adbezogene Sequen\u00adzierung im Rahmen der Coronavirus-Surveillance\u00adverordnung (CorSurV)."},{"key":"1647_CR9","doi-asserted-by":"publisher","unstructured":"Robert Koch-Institut. SARS-CoV-2-Sequenzdaten aus Deutschland. Zenodo https:\/\/doi.org\/10.5281\/zenodo.11386775 (2024).","DOI":"10.5281\/zenodo.11386775"},{"key":"1647_CR10","doi-asserted-by":"publisher","unstructured":"Wise, J. Covid-19: WHO declares end of global health emergency. BMJ 381 https:\/\/doi.org\/10.1136\/bmj.p1041 (2023).","DOI":"10.1136\/bmj.p1041"},{"key":"1647_CR11","unstructured":"ECDC. Operational considerations for respiratory virus surveillance in Europe, 18 July 2022. https:\/\/www.ecdc.europa.eu\/sites\/default\/files\/documents\/Operational-considerations-respiratory-virus-surveillance-euro-2022.pdf (2022)."},{"key":"1647_CR12","doi-asserted-by":"publisher","first-page":"S110","DOI":"10.1093\/cid\/ciac399","volume":"75","author":"DY Oh","year":"2022","unstructured":"Oh, D. Y. et al. Advancing precision vaccinology by molecular and genomic surveillance of severe acute respiratory syndrome Coronavirus 2 in Germany, 2021. Clin. Infect. Dis. 75, S110\u2013S120 (2022).","journal-title":"Clin. Infect. Dis."},{"key":"1647_CR13","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1038\/s41586-024-08477-8","volume":"639","author":"NA Raharinirina","year":"2025","unstructured":"Raharinirina, N. A. et al. SARS-CoV-2 evolution on a dynamic immune landscape. Nature 639, 196\u2013204 (2025).","journal-title":"Nature"},{"key":"1647_CR14","doi-asserted-by":"publisher","first-page":"1138","DOI":"10.1038\/s42003-022-04068-3","volume":"5","author":"C Mache","year":"2022","unstructured":"Mache, C. et al. SARS-CoV-2 Omicron variant is attenuated for replication in a polarized human lung epithelial cell model. Commun. Biol. 5, 1138 (2022).","journal-title":"Commun. Biol."},{"key":"1647_CR15","doi-asserted-by":"publisher","unstructured":"Mache, C. et al. Monitoring viral evolution and epidemiological characteristics of SARS-CoV-2 during 2022\u20132023 using Integrated Genomic Surveillance. Zenodo https:\/\/doi.org\/10.5281\/zenodo.19383697 (2026).","DOI":"10.5281\/zenodo.19383697"},{"key":"1647_CR16","doi-asserted-by":"publisher","first-page":"711437","DOI":"10.3389\/fgene.2021.711437","volume":"12","author":"C Brandt","year":"2021","unstructured":"Brandt, C. et al. poreCov-An Easy to Use, Fast, and Robust Workflow for SARS-CoV-2 Genome Reconstruction via Nanopore Sequencing. Front. Genet. 12, 711437 (2021).","journal-title":"Front. Genet."},{"key":"1647_CR17","doi-asserted-by":"publisher","unstructured":"Leger, A. & Leonardi, T. pycoQC, interactive quality control for Oxford Nanopore Sequencing. J. Open Source Softw. 4 https:\/\/doi.org\/10.21105\/joss.01236 (2019).","DOI":"10.21105\/joss.01236"},{"key":"1647_CR18","doi-asserted-by":"publisher","DOI":"10.1186\/s13059-019-1891-0","volume":"20","author":"DE Wood","year":"2019","unstructured":"Wood, D. E., Lu, J. & Langmead, B. Improved metagenomic analysis with Kraken 2. Genome Biol. 20, 257 (2019).","journal-title":"Genome Biol."},{"key":"1647_CR19","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2105-12-385","volume":"12","author":"BD Ondov","year":"2011","unstructured":"Ondov, B. D., Bergman, N. H. & Phillippy, A. M. Interactive metagenomic visualization in a Web browser. BMC Bioinforma. 12, 385 (2011).","journal-title":"BMC Bioinforma."},{"key":"1647_CR20","doi-asserted-by":"publisher","unstructured":"Aksamentov, I., Roemer, C., Hodcroft, E. & Neher, R. Nextclade: clade assignment, mutation calling and quality control for viral genomes. J. Open Source Softw. 6 https:\/\/doi.org\/10.21105\/joss.03773 (2021).","DOI":"10.21105\/joss.03773"},{"key":"1647_CR21","doi-asserted-by":"publisher","first-page":"1403","DOI":"10.1038\/s41564-020-0770-5","volume":"5","author":"A Rambaut","year":"2020","unstructured":"Rambaut, A. et al. A dynamic nomenclature proposal for SARS-CoV-2 lineages to assist genomic epidemiology. Nat. Microbiol. 5, 1403\u20131407 (2020).","journal-title":"Nat. Microbiol."},{"key":"1647_CR22","doi-asserted-by":"crossref","first-page":"W5","DOI":"10.1093\/nar\/gky874","volume":"47","author":"J Rozewicki","year":"2019","unstructured":"Rozewicki, J., Li, S., Amada, K. M., Standley, D. M. & Katoh, K. MAFFT-DASH: integrated protein sequence and structural alignment. Nucleic Acids Res. 47, W5\u2013W10 (2019).","journal-title":"Nucleic Acids Res."},{"key":"1647_CR23","doi-asserted-by":"publisher","first-page":"1530","DOI":"10.1093\/molbev\/msaa015","volume":"37","author":"BQ Minh","year":"2020","unstructured":"Minh, B. Q. et al. IQ-TREE 2: New Models and Efficient Methods for Phylogenetic Inference in the Genomic Era. Mol. Biol. Evol. 37, 1530\u20131534 (2020).","journal-title":"Mol. Biol. Evol."},{"key":"1647_CR24","doi-asserted-by":"publisher","first-page":"518","DOI":"10.1093\/molbev\/msx281","volume":"35","author":"DT Hoang","year":"2018","unstructured":"Hoang, D. T., Chernomor, O., von Haeseler, A., Minh, B. Q. & Vinh, L. S. UFBoot2: Improving the Ultrafast Bootstrap Approximation. Mol. Biol. Evol. 35, 518\u2013522 (2018).","journal-title":"Mol. Biol. Evol."},{"key":"1647_CR25","doi-asserted-by":"publisher","unstructured":"Moore, R. M., Harrison, A. O., McAllister, S. M., Polson, S. W., & Wommack, K. E. Iroki: automatic customization and visualization of phylogenetic trees. PeerJ https:\/\/doi.org\/10.7717\/peerj.8584 (2020).","DOI":"10.7717\/peerj.8584"},{"key":"1647_CR26","doi-asserted-by":"publisher","DOI":"10.1186\/s12864-018-4620-2","volume":"19","author":"U Mai","year":"2018","unstructured":"Mai, U. & Mirarab, S. TreeShrink: fast and accurate detection of outlier long branches in collections of phylogenetic trees. BMC Genomics 19, 272 (2018).","journal-title":"BMC Genomics"},{"key":"1647_CR27","unstructured":"R-Core-Team. _R: A Language and Environment for Statistical Computing_. R Foundation for Statistical Computing, Vienna, Austria. https:\/\/www.R-project.org\/ (2024)."},{"key":"1647_CR28","unstructured":"GitHub. BJ.1\/BM.1.1.1 (=BA.2.75.3.1.1.1) recombinant with breakpoint in S1 [> = 5 sequences, 3x Singapore, 2x US as of 2022-09-12] (September 13, 2022). https:\/\/github.com\/cov-lineages\/pangodesignation\/issues\/1058. (2022)."},{"key":"1647_CR29","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-023-38435-3","volume":"14","author":"T Tamura","year":"2023","unstructured":"Tamura, T. et al. Virological characteristics of the SARS-CoV-2 XBB variant derived from recombination of two Omicron subvariants. Nat. Commun. 14, 2800 (2023).","journal-title":"Nat. Commun."},{"key":"1647_CR30","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1038\/s41579-023-00878-2","volume":"21","author":"PV Markov","year":"2023","unstructured":"Markov, P. V. et al. The evolution of SARS-CoV-2. Nat. Rev. Microbiol. 21, 361\u2013379 (2023).","journal-title":"Nat. Rev. Microbiol."},{"key":"1647_CR31","doi-asserted-by":"publisher","first-page":"651","DOI":"10.15585\/mmwr.mm7224a2","volume":"72","author":"K Ma","year":"2023","unstructured":"Ma, K. et al. Genomic Surveillance for SARS-CoV-2 Variants: Circulation of Omicron Lineages \u2014 United States, January 2022\u2013May 2023. Mmwr. Morbid. Mortal. Wkly. Rep. 72, 651\u2013656 (2023).","journal-title":"Mmwr. Morbid. Mortal. Wkly. Rep."},{"key":"1647_CR32","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1038\/s41586-022-05053-w","volume":"608","author":"Q Wang","year":"2022","unstructured":"Wang, Q. et al. Antibody evasion by SARS-CoV-2 Omicron subvariants BA.2.12.1, BA.4 and BA.5. Nature 608, 603\u2013608 (2022).","journal-title":"Nature"},{"key":"1647_CR33","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-023-37059-x","volume":"14","author":"R Uraki","year":"2023","unstructured":"Uraki, R. et al. Characterization of SARS-CoV-2 Omicron BA.2.75 clinical isolates. Nat. Commun. 14, 1620 (2023).","journal-title":"Nat. Commun."},{"key":"1647_CR34","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1038\/s41392-022-01105-9","volume":"7","author":"S Xia","year":"2022","unstructured":"Xia, S., Wang, L., Zhu, Y., Lu, L. & Jiang, S. Origin, virological features, immune evasion and intervention of SARS-CoV-2 Omicron sublineages. Signal Transduct. Target. Ther. 7, 241 (2022).","journal-title":"Signal Transduct. Target. Ther."},{"key":"1647_CR35","doi-asserted-by":"publisher","first-page":"1011","DOI":"10.1056\/NEJMra2206573","volume":"387","author":"DH Barouch","year":"2022","unstructured":"Barouch, D. H. Covid-19 Vaccines - Immunity, Variants, Boosters. N. Engl. J. Med. 387, 1011\u20131020 (2022).","journal-title":"N. Engl. J. Med."},{"key":"1647_CR36","doi-asserted-by":"publisher","unstructured":"Planas, D. et al. Distinct evolution of SARS-CoV-2 Omicron XBB and BA.2.86\/JN.1 lineages combining increased fitness and antibody evasion. Nat, Commun. https:\/\/doi.org\/10.1038\/s41467-024-46490-7 (2024).","DOI":"10.1038\/s41467-024-46490-7"},{"key":"1647_CR37","doi-asserted-by":"publisher","first-page":"2200396","DOI":"10.2807\/1560-7917.ES.2022.27.22.2200396","volume":"27","author":"C Sievers","year":"2022","unstructured":"Sievers, C. et al. SARS-CoV-2 Omicron variants BA.1 and BA.2 both show similarly reduced disease severity of COVID-19 compared to Delta, Germany, 2021 to 2022. Eurosurveillance 27, 2200396 (2022).","journal-title":"Eurosurveillance"},{"key":"1647_CR38","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1038\/s41392-022-00997-x","volume":"7","author":"Y Fan","year":"2022","unstructured":"Fan, Y. et al. SARS-CoV-2 Omicron variant: recent progress and future perspectives. Signal Transduct. Target. Ther. 7, 141 (2022).","journal-title":"Signal Transduct. Target. Ther."},{"key":"1647_CR39","doi-asserted-by":"publisher","unstructured":"Kuger, S. et al. Kindertagesbetreuung und Infektionsgeschehen w\u00e4hrend der COVID-19-Pandemie. Abschlussbericht der Corona-KiTa-Studie. https:\/\/doi.org\/10.3278\/9783763973279 (2022).","DOI":"10.3278\/9783763973279"},{"key":"1647_CR40","doi-asserted-by":"publisher","unstructured":"Goller, K. V. et al. Clinical manifestations of infections with the Omicron sub-lineages BA.1, BA.2, and BA.5: a retrospective follow-up analysis of public health data from Mecklenburg-Western Pomerania, Germany. Viruses 16 https:\/\/doi.org\/10.3390\/v16030454 (2024).","DOI":"10.3390\/v16030454"},{"key":"1647_CR41","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-022-33614-0","volume":"13","author":"N Wolter","year":"2022","unstructured":"Wolter, N. et al. Clinical severity of SARS-CoV-2 Omicron BA.4 and BA.5 lineages compared to BA.1 and Delta in South Africa. Nat. Commun. 13, 5860 (2022).","journal-title":"Nat. Commun."},{"key":"1647_CR42","unstructured":"STIKO. Beschluss der STIKO zur 13. Aktualisierung der COVID-19-Impfempfehlung. Epidemiologisches Bulletin, 10\u201319 (2021)."},{"key":"1647_CR43","unstructured":"STIKO. Beschluss der STIKO zur 17. Aktualisierung der COVID-19-Impfempfehlung. Epidemiologisches Bulletin, 7\u201320 (2022)."},{"key":"1647_CR44","first-page":"765","volume":"119","author":"R Ott","year":"2022","unstructured":"Ott, R. et al. SARS-CoV-2 Seroprevalence in preschool and school-age children-population screening findings From January 2020 to June 2022. Dtsch \u00c4rztebl Int 119, 765\u2013770 (2022).","journal-title":"Dtsch \u00c4rztebl Int"},{"key":"1647_CR45","doi-asserted-by":"publisher","first-page":"1531","DOI":"10.1007\/s15010-023-02052-5","volume":"51","author":"G Engels","year":"2023","unstructured":"Engels, G. et al. SARS-CoV-2 sero-immunity and quality of life in children and adolescents in relation to infections and vaccinations: the IMMUNEBRIDGE KIDS cross-sectional study, 2022. Infection 51, 1531\u20131539 (2023).","journal-title":"Infection"},{"key":"1647_CR46","doi-asserted-by":"publisher","first-page":"698","DOI":"10.1056\/NEJMc2119236","volume":"386","author":"A Rossler","year":"2022","unstructured":"Rossler, A., Riepler, L., Bante, D., von Laer, D. & Kimpel, J. SARS-CoV-2 Omicron Variant Neutralization in Serum from Vaccinated and Convalescent Persons. N. Engl. J. Med. 386, 698\u2013700 (2022).","journal-title":"N. Engl. J. Med."},{"key":"1647_CR47","doi-asserted-by":"publisher","first-page":"eabq4450","DOI":"10.1126\/sciimmunol.abq4450","volume":"7","author":"AZ Mykytyn","year":"2022","unstructured":"Mykytyn, A. Z. et al. Antigenic cartography of SARS-CoV-2 reveals that Omicron BA.1 and BA.2 are antigenically distinct. Sci. Immunol. 7, eabq4450 (2022).","journal-title":"Sci. Immunol."},{"key":"1647_CR48","doi-asserted-by":"publisher","unstructured":"Eggink, D. et al. Increased risk of infection with SARS-CoV-2 Omicron BA.1 compared with Delta in vaccinated and previously infected individuals, the Netherlands, 22 November 2021 to 19 January 2022. Euro surveillance: bulletin Europ\u00e9en sur les maladies transmissibles = European communicable disease bulletin 27 https:\/\/doi.org\/10.2807\/1560-7917.ES.2022.27.4.2101196 (2022).","DOI":"10.2807\/1560-7917.ES.2022.27.4.2101196"},{"key":"1647_CR49","doi-asserted-by":"publisher","first-page":"eabn4947","DOI":"10.1126\/science.abn4947","volume":"376","author":"JRC Pulliam","year":"2022","unstructured":"Pulliam, J. R. C. et al. Increased risk of SARS-CoV-2 reinfection associated with emergence of Omicron in South Africa. Science 376, eabn4947 (2022).","journal-title":"Science"},{"key":"1647_CR50","doi-asserted-by":"publisher","first-page":"1532","DOI":"10.1056\/NEJMoa2119451","volume":"386","author":"N Andrews","year":"2022","unstructured":"Andrews, N. et al. COVID-19 Vaccine Effectiveness against the Omicron (B.1.1.529) Variant. N. Engl. J. Med. 386, 1532\u20131546 (2022).","journal-title":"N. Engl. J. Med."},{"key":"1647_CR51","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1038\/s41586-022-04980-y","volume":"608","author":"Y Cao","year":"2022","unstructured":"Cao, Y. et al. BA.2.12.1, BA.4 and BA.5 escape antibodies elicited by Omicron infection. Nature 608, 593\u2013602 (2022).","journal-title":"Nature"},{"key":"1647_CR52","doi-asserted-by":"publisher","first-page":"1827","DOI":"10.1016\/S0140-6736(23)02278-X","volume":"402","author":"Q Wang","year":"2023","unstructured":"Wang, Q. et al. SARS-CoV-2 neutralising antibodies after a second BA.5 bivalent booster. Lancet 402, 1827\u20131828 (2023).","journal-title":"Lancet"},{"key":"1647_CR53","doi-asserted-by":"publisher","first-page":"1971","DOI":"10.1038\/s41564-023-01505-9","volume":"8","author":"CQ Huang","year":"2023","unstructured":"Huang, C. Q., Vishwanath, S., Carnell, G. W., Chan, A. C. Y. & Heeney, J. L. Immune imprinting and next-generation coronavirus vaccines. Nat. Microbiol. 8, 1971\u20131985 (2023).","journal-title":"Nat. Microbiol."},{"key":"1647_CR54","doi-asserted-by":"publisher","first-page":"2384192","DOI":"10.1080\/21645515.2024.2384192","volume":"20","author":"M Maltseva","year":"2024","unstructured":"Maltseva, M., Keeshan, A., Cooper, C. & Langlois, M. A. Immune imprinting: The persisting influence of the first antigenic encounter with rapidly evolving viruses. Hum. Vaccin Immunother. 20, 2384192 (2024).","journal-title":"Hum. Vaccin Immunother."},{"key":"1647_CR55","doi-asserted-by":"publisher","first-page":"945","DOI":"10.1016\/j.healthpol.2022.07.005","volume":"126","author":"D Ghio","year":"2022","unstructured":"Ghio, D., Bignami-Van Assche, S. & Stilianakis, N. I. Demographics of COVID-19 hospitalisations and related fatality risk patterns. Health Policy 126, 945\u2013955 (2022).","journal-title":"Health Policy"},{"key":"1647_CR56","doi-asserted-by":"publisher","first-page":"ofab448","DOI":"10.1093\/ofid\/ofab448","volume":"8","author":"EP Scully","year":"2021","unstructured":"Scully, E. P. et al. Sex and gender differences in testing, hospital admission, clinical presentation, and drivers of severe outcomes from COVID-19. Open Forum Infect. Dis. 8, ofab448 (2021).","journal-title":"Open Forum Infect. Dis."},{"key":"1647_CR57","doi-asserted-by":"publisher","first-page":"1159","DOI":"10.1007\/s10654-022-00919-9","volume":"37","author":"J Sieurin","year":"2022","unstructured":"Sieurin, J., Brand\u00e9n, G., Magnusson, C., Hergens, M.-P. & Kosidou, K. A population-based cohort study of sex and risk of severe outcomes in COVID-19. Eur. J. Epidemiol. 37, 1159\u20131169 (2022).","journal-title":"Eur. J. Epidemiol."},{"key":"1647_CR58","doi-asserted-by":"publisher","first-page":"1144","DOI":"10.3201\/eid3006.231285","volume":"30","author":"I Griffin","year":"2024","unstructured":"Griffin, I. et al. Estimates of SARS-CoV-2 Hospitalization and Fatality Rates in the Prevaccination Period, United States. Emerg. Infect. Dis. 30, 1144\u20131153 (2024).","journal-title":"Emerg. Infect. Dis."},{"key":"1647_CR59","doi-asserted-by":"publisher","first-page":"1939","DOI":"10.3201\/eid3009.240640","volume":"30","author":"A Loenenbach","year":"2024","unstructured":"Loenenbach, A. et al. Participatory, Virologic, and Wastewater Surveillance Data to Assess Underestimation of COVID-19 Incidence, Germany, 2020\u20132024. Emerg. Infect. Dis. J. 30, 1939 (2024).","journal-title":"Emerg. Infect. Dis. J."},{"key":"1647_CR60","unstructured":"ECDC. Guidance for representative and targeted genomic SARS-CoV-2 monitoring \u2013 3 May 2021. European Centre for Disease Prevention and Control (2021)."},{"key":"1647_CR61","doi-asserted-by":"publisher","first-page":"L25","DOI":"10.1152\/ajplung.00256.2010","volume":"300","author":"AA Pezzulo","year":"2011","unstructured":"Pezzulo, A. A. et al. The air-liquid interface and use of primary cell cultures are important to recapitulate the transcriptional profile of in vivo airway epithelia. Am. J. Physiol. Lung Cell Mol. Physiol. 300, L25\u2013L31 (2011).","journal-title":"Am. J. Physiol. Lung Cell Mol. Physiol."},{"key":"1647_CR62","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-024-45075-8","volume":"15","author":"G Shi","year":"2024","unstructured":"Shi, G. et al. Omicron Spike confers enhanced infectivity and interferon resistance to SARS-CoV-2 in human nasal tissue. Nat. Commun. 15, 889 (2024).","journal-title":"Nat. Commun."},{"key":"1647_CR63","doi-asserted-by":"publisher","unstructured":"Peacock, T. P. et al. The SARS-CoV-2 variant, Omicron, shows rapid replication in human primary nasal epithelial cultures and efficiently uses the endosomal route of entry. bioRxiv https:\/\/doi.org\/10.1101\/2021.12.31.474653 (2022).","DOI":"10.1101\/2021.12.31.474653"},{"key":"1647_CR64","doi-asserted-by":"publisher","first-page":"1161","DOI":"10.1038\/s41564-022-01143-7","volume":"7","author":"BJ Willett","year":"2022","unstructured":"Willett, B. J. et al. SARS-CoV-2 Omicron is an immune escape variant with an altered cell entry pathway. Nat. Microbiol. 7, 1161\u20131179 (2022).","journal-title":"Nat. Microbiol."},{"key":"1647_CR65","doi-asserted-by":"publisher","first-page":"20230187","DOI":"10.1098\/rsif.2023.0187","volume":"20","author":"CP McCormack","year":"2023","unstructured":"McCormack, C. P. et al. Modelling the viral dynamics of the SARS-CoV-2 Delta and Omicron variants in different cell types. J. R. Soc. Interface 20, 20230187 (2023).","journal-title":"J. R. Soc. Interface"},{"key":"1647_CR66","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-022-33632-y","volume":"13","author":"GT Barut","year":"2022","unstructured":"Barut, G. T. et al. The spike gene is a major determinant for the SARS-CoV-2 Omicron-BA.1 phenotype. Nat. Commun. 13, 5929 (2022).","journal-title":"Nat. Commun."},{"key":"1647_CR67","doi-asserted-by":"publisher","first-page":"700","DOI":"10.1038\/s41586-022-04462-1","volume":"603","author":"R Suzuki","year":"2022","unstructured":"Suzuki, R. et al. Attenuated fusogenicity and pathogenicity of SARS-CoV-2 Omicron variant. Nature 603, 700\u2013705 (2022).","journal-title":"Nature"},{"key":"1647_CR68","doi-asserted-by":"publisher","DOI":"10.1128\/mbio.03129-23","volume":"15","author":"N Tanneti","year":"2024","unstructured":"Tanneti, N. et al. Comparison of SARS-CoV-2 variants of concern in primary human nasal cultures demonstrates Delta as most cytopathic and Omicron as fastest replicating. mBio 15, e03129\u201303123 (2024).","journal-title":"mBio"},{"key":"1647_CR69","doi-asserted-by":"publisher","unstructured":"Do, T. N. D., Claes, S., Schols, D., Neyts, J. & Jochmans, D. SARS-CoV-2 Virion infectivity and cytokine production in primary human airway epithelial cells. Viruses 14 https:\/\/doi.org\/10.3390\/v14050951 (2022).","DOI":"10.3390\/v14050951"},{"key":"1647_CR70","doi-asserted-by":"publisher","first-page":"715","DOI":"10.1038\/s41586-022-04479-6","volume":"603","author":"KPY Hui","year":"2022","unstructured":"Hui, K. P. Y. et al. SARS-CoV-2 Omicron variant replication in human bronchus and lung ex vivo. Nature 603, 715\u2013720 (2022).","journal-title":"Nature"},{"key":"1647_CR71","doi-asserted-by":"publisher","unstructured":"Halfmann, P. J. et al. SARS-CoV-2 Omicron virus causes attenuated disease in mice and hamsters. Nature https:\/\/doi.org\/10.1038\/s41586-022-04441-6 (2022).","DOI":"10.1038\/s41586-022-04441-6"},{"key":"1647_CR72","doi-asserted-by":"publisher","unstructured":"Shuai, H. et al. Attenuated replication and pathogenicity of SARS-CoV-2 B.1.1.529 Omicron. Nature https:\/\/doi.org\/10.1038\/s41586-022-04442-5 (2022).","DOI":"10.1038\/s41586-022-04442-5"},{"key":"1647_CR73","doi-asserted-by":"publisher","first-page":"1540","DOI":"10.1016\/j.chom.2022.10.003","volume":"30","author":"A Saito","year":"2022","unstructured":"Saito, A. et al. Virological characteristics of the SARS-CoV-2 Omicron BA.2.75 variant. Cell Host Microbe 30, 1540\u20131555.e1515 (2022).","journal-title":"Cell Host Microbe"},{"key":"1647_CR74","doi-asserted-by":"publisher","first-page":"113580","DOI":"10.1016\/j.celrep.2023.113580","volume":"42","author":"R Uraki","year":"2023","unstructured":"Uraki, R. et al. Characterization of a SARS-CoV-2 EG.5.1 clinical isolate in vitro and in vivo. Cell Rep. 42, 113580 (2023).","journal-title":"Cell Rep."},{"key":"1647_CR75","doi-asserted-by":"publisher","first-page":"4953","DOI":"10.1016\/j.cell.2021.08.016","volume":"184","author":"B Sposito","year":"2021","unstructured":"Sposito, B. et al. The interferon landscape along the respiratory tract impacts the severity of COVID-19. Cell 184, 4953\u20134968 e4916 (2021).","journal-title":"Cell"},{"key":"1647_CR76","doi-asserted-by":"publisher","first-page":"pgac067","DOI":"10.1093\/pnasnexus\/pgac067","volume":"1","author":"L Shalamova","year":"2022","unstructured":"Shalamova, L. et al. Omicron variant of SARS-CoV-2 exhibits an increased resilience to the antiviral type I interferon response. PNAS Nexus 1, pgac067 (2022).","journal-title":"PNAS Nexus"},{"key":"1647_CR77","doi-asserted-by":"publisher","unstructured":"Maslo, C. et al. Characteristics and Outcomes of Hospitalized Patients in South Africa During the COVID-19 Omicron Wave Compared With Previous Waves. JAMA https:\/\/doi.org\/10.1001\/jama.2021.24868 (2021).","DOI":"10.1001\/jama.2021.24868"},{"key":"1647_CR78","doi-asserted-by":"publisher","unstructured":"Van Goethem, N. et al. Clinical Severity of SARS-CoV-2 Omicron Variant Compared with Delta among Hospitalized COVID-19 Patients in Belgium during Autumn and Winter Season 2021\u20132022. Viruses 14 https:\/\/doi.org\/10.3390\/v14061297 (2022).","DOI":"10.3390\/v14061297"},{"key":"1647_CR79","doi-asserted-by":"publisher","first-page":"1618","DOI":"10.1016\/S0140-6736(22)00327-0","volume":"399","author":"C Menni","year":"2022","unstructured":"Menni, C. et al. Symptom prevalence, duration, and risk of hospital admission in individuals infected with SARS-CoV-2 during periods of omicron and delta variant dominance: a prospective observational study from the ZOE COVID Study. Lancet 399, 1618\u20131624 (2022).","journal-title":"Lancet"},{"key":"1647_CR80","doi-asserted-by":"publisher","unstructured":"Brangel, P. et al. A Global Collaborative Comparison of SARS-CoV-2 Antigenicity Across 15 Laboratories. Viruses 16 https:\/\/doi.org\/10.3390\/v16121936 (2024).","DOI":"10.3390\/v16121936"},{"key":"1647_CR81","doi-asserted-by":"publisher","unstructured":"Jeworowski, L. M. et al. Humoral immune escape by current SARS-CoV-2 variants BA.2.86 and JN.1, December 2023. Eur. Commun. Dis. Bull. 29 https:\/\/doi.org\/10.2807\/1560-7917.ES.2024.29.2.2300740 (2024).","DOI":"10.2807\/1560-7917.ES.2024.29.2.2300740"},{"key":"1647_CR82","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1016\/j.cell.2023.12.026","volume":"187","author":"P Qu","year":"2024","unstructured":"Qu, P. et al. Immune evasion, infectivity, and fusogenicity of SARS-CoV-2 BA.2.86 and FLip variants. Cell 187, 585\u2013595 e586 (2024).","journal-title":"Cell"},{"key":"1647_CR83","doi-asserted-by":"publisher","first-page":"6904","DOI":"10.1016\/j.vaccine.2023.10.051","volume":"41","author":"N Lasrado","year":"2023","unstructured":"Lasrado, N. et al. Neutralization escape by SARS-CoV-2 Omicron subvariant BA.2.86. Vaccine 41, 6904\u20136909 (2023).","journal-title":"Vaccine"}],"container-title":["Communications Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s43856-026-01647-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s43856-026-01647-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s43856-026-01647-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,26]],"date-time":"2026-05-26T18:02:36Z","timestamp":1779818556000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s43856-026-01647-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,26]]},"references-count":83,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["1647"],"URL":"https:\/\/doi.org\/10.1038\/s43856-026-01647-x","relation":{},"ISSN":["2730-664X"],"issn-type":[{"value":"2730-664X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,26]]},"assertion":[{"value":"27 May 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 April 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 May 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"305"}}